Solid Biosciences convened Friedreich’s ataxia patient advocates at PPD CRO’s GMP Lab in Wisconsin, highlighting patient input in its rare-disease research stra

Solid Biosciences convened Friedreich’s ataxia patient advocates at PPD CRO’s GMP Lab in Wisconsin, highlighting patient input in its rare-disease research strategy. The company shared FA program insights, but disclosed no specific next steps or outcomes.